Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Jony van Hilst

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0003-4990-445X; OpenAlex author ID A5032835526. Sources: ClinicalTrials.gov.

Their work

Papers
13 (first author 3, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
70
Papers, trials and grants by year

2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: 4 papers · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper, 1 trial

Papers 13

  1. Splenic hilum nodal involvement in resected left-sided pancreatic cancer: meta-analysis. Last author DOI 10.1093/bjsopen/zrag153↗
  2. Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA Trial. First author DOI 10.1001/jamasurg.2025.4054↗
  3. The value of splenectomy during left-sided pancreatectomy for pancreatic ductal adenocarcinoma: predefined subanalysis in the DIPLOMA randomized trial. First author DOI 10.1093/bjs/znae236↗
  4. Minimally invasive versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: Individual patient data meta-analysis of randomized trials. Co-author DOI 10.1016/j.ejso.2023.03.227↗
  5. Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial. Co-author DOI 10.1016/j.lanepe.2023.100673↗
  6. Laparoscopic versus open extended radical left pancreatectomy for pancreatic ductal adenocarcinoma: an international propensity-score matched study. First author DOI 10.1007/s00464-020-08206-y↗
  7. Outcomes of Elective and Emergency Conversion in Minimally Invasive Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma: An International Multicenter Pr… Co-author DOI 10.1097/sla.0000000000003717↗
  8. Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial. Co-author DOI 10.1186/s13063-021-05506-z↗
  9. Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-020-08658-5↗
  10. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Sco… Co-author DOI 10.1245/s10434-019-08137-6↗
  11. Oncologic outcomes of minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Co-author DOI 10.1016/j.ejso.2018.12.003↗
  12. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6391-z↗
  13. Correction to: Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Co-author DOI 10.1245/s10434-018-6442-5↗

Trials 1

  1. Spleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID) Principal investigator NCT07799298↗

Closest collaborators

The 25 strongest of 70 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marc G. Besselink · 10 shared papers, 1 shared trial, 2018–2026 · strength 1.97
  2. Mohammad Abu Hilal · 8 shared papers, 2019–2026 · strength 1.11
  3. Mohammad Abu Hilal · 1 shared trial, 2026 · strength 0.75
  4. Ugo Boggi · 7 shared papers, 2018–2024 · strength 0.62
  5. Maarten Korrel · 6 shared papers, 2019–2024 · strength 0.61
  6. Giuseppe Malleo · 3 shared papers, 2020–2026 · strength 0.53
  7. Sanne Lof · 5 shared papers, 2019–2021 · strength 0.48
  8. C.L. Bruna · 2 shared papers, 2024–2026 · strength 0.47
  9. Matteo De Pastena · 5 shared papers, 2018–2024 · strength 0.44
  10. Safi Dokmak · 4 shared papers, 2020–2024 · strength 0.42
  11. Giovanni Butturini · 4 shared papers, 2020–2024 · strength 0.42
  12. Massimo Falconi · 4 shared papers, 2020–2024 · strength 0.42
  13. Tobias Keck · 4 shared papers, 2020–2024 · strength 0.41
  14. Adnan A. Alseidi · 4 shared papers, 2020–2024 · strength 0.41
  15. Bjørn Edwin · 4 shared papers, 2020–2021 · strength 0.39
  16. Alessandro Zerbi · 3 shared papers, 2020–2024 · strength 0.33
  17. Thilo Hackert · 3 shared papers, 2021–2024 · strength 0.32
  18. Igor E Khatkov · 3 shared papers, 2021–2024 · strength 0.32
  19. Roberto Salvia · 4 shared papers, 2018–2024 · strength 0.32
  20. Claudio Bassi · 4 shared papers, 2018–2021 · strength 0.32
  21. Bas Groot Koerkamp · 3 shared papers, 2019–2024 · strength 0.31
  22. Riccardo Casadei · 3 shared papers, 2020–2024 · strength 0.31
  23. David A. Kooby · 2 shared papers, 2019–2024 · strength 0.23
  24. Aleš Tomažič · 2 shared papers, 2020–2024 · strength 0.22
  25. Gianpaolo Balzano · 2 shared papers, 2020–2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.